England seeks views on including men in HPV vaccine programme
This article was originally published in Scrip
Just as the UK's NHS prepares to switch from GlaxoSmithKline's human papillomavirus vaccine Cervarix to Sanofi Pasteur MSD's Gardasil, England's Joint Committee on Vaccination and Immunisation has put out a call for evidence on whether it should amend its HPV immunisation programme to include men. It will be considering how some men might benefit from vaccination and the potential impact of higher valency vaccines.
You may also be interested in...
Softening provisions to make EU-wide joint clinical assessments voluntary would make proposed legislation on HTA cooperation redundant, says Eurordis.
Plans for EU-wide Joint Clinical assessments will come under scrutiny at an EU council meeting next week.
Pfizer’s Ibrance has won conditional reimbursement in England while more data is gathered to reduce some uncertainty.